VAERS reports by lot

GSK Varicella/Shingles lot 252N2: VAERS reports

28 VAERS reports list lot 252N2 as a GSK Varicella/Shingles vaccine, received between 2019-10-30 and 2020-12-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
28
Reports
0%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1520%
Dermatological (non-injection-site)1216%
Neurological1115%
Gastrointestinal1115%
General / Systemic (non-local)1013%
Musculoskeletal68%
Allergic / Anaphylactic57%
Cardiac / Cardiovascular45%
Respiratory11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Georgia4
Virginia3
New Jersey3
Pennsylvania2
Washington2
California2
West Virginia2
Alabama1
Missouri1
Arizona1
Minnesota1
New York1

Reports by month received

2019-102
2019-1110
2019-124
2020-016
2020-021
2020-061
2020-091
2020-101
2020-122

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.